Theratechnologies Inc. (TH) — Capital Reinvestment Ratio

Latest as of May 2025: 3.80x

Theratechnologies Inc. (TH) has a Capital Reinvestment Ratio of 3.80x as of May 2025, meaning it reinvests 4% of its operating cash flow (CA$2.66 Million) in capital expenditures (CA$10.11 Million). Check Theratechnologies Inc. tangible equity quality to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

3.80x
Capex / Operating Cash Flow

Operating Cash Flow

CA$2.66 Million
CAD

Capital Expenditures

CA$10.11 Million
CAD

Data as of

May 2025
Most recent filing

Theratechnologies Inc. Capital Reinvestment Ratio (2009–2024)

This chart tracks Theratechnologies Inc.'s Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see TH cash flow conversion.

Annual Capital Reinvestment Ratio for Theratechnologies Inc. (2009–2024)

Year-by-year Capital Reinvestment Ratio for Theratechnologies Inc. from 2009 to 2024. See TH free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (CAD) Capital Expenditures YoY Change
2024 0.63x CA$2.38 Million CA$1.50 Million ▲ +1529.4%
2017 0.04x CA$1.91 Million CA$73.82K ▼ -93.5%
2016 0.59x CA$2.00 Million CA$1.19 Million ▲ +10058.0%
2015 0.01x CA$5.30 Million CA$31.00K ▼ -95.9%
2010 0.14x CA$2.84 Million CA$407.05K ▲ +98.9%
2009 0.07x CA$5.35 Million CA$384.80K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow